3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
3
Pancreatic Cyst
2
Subepithelial Gastrointestinal Tumors
1
Stomach Neoplasms
1
Peutz-Jeghers Syndrome
1
Pancreatic carcinoma, familial
1
Pancreatic adenoma
1
Pancreatic Intraductal Neoplasms
1
Other Specified Disorders of Esophagus, Stomach or Duodenum
1
Neoplasms, Unknown Primary
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Lymphatic Metastasis
1
Lymphadenopathy
1
Hereditary pancreatitis
1
Esophageal Neoplasms
1
Dysplastic Nevus Syndrome
1
Duodenal Neoplasms
1
Disease
1
Cysts
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Biopsy, Fine-Needle
1
Arachnodactyly
1
Adenoma, Islet Cell
1
Interventions
recombinant interferon alpha 2b-like protein
1
Thalidomide
1
Temozolomide
1
Tegafur
1
Surveys and Questionnaires
1
Phlebotomy
1
Pancreatectomy
1
Metformin
1
Injections
1
Everolimus
1
Endoscopic Ultrasound-Guided Fine Needle Aspiration
1
Chromogranin A
1
Biopsy, Large-Core Needle
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Adenoma, Islet Cell
×
Endoscopic Ultrasound-Guided Fine Needle Aspiration
×
Clear all
NCT01563133
2017-08-29
CONTACT
Mauna Kea Technologies
Phase NA
Unknown
330 enrolled